Key terms
About BNGO
Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on the genome analysis space. The firm engages in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline cytogenetics. Its products include Saphyr, Bionano Chips, Bionano Prep Kits, and Bionano Data Solutions. The company was founded by Han Cao in January 2003 and is headquartered in San Diego, CA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest BNGO news
Mar 19
8:15am ET
Bionano Genomics announces publication of a breast cancer study with OGM
Mar 09
11:15am ET
BioNano Genomics (BNGO) Gets a Hold from Maxim Group
Mar 07
8:20am ET
Bionano Genomics announces lineup of content at ACMG
Mar 07
1:01am ET
A New Cause for Concern: Bionano Genomics Adds a New Share Price & Shareholder Rights Risk
Mar 05
4:10pm ET
Bionano Genomics sees Q1 revenue $8.25M-$8.75M, consensus $9.69M
Mar 05
4:08pm ET
Bionano Genomics sees FY24 revenue $37M $41M, consensus $47.17M
Mar 05
4:06pm ET
Bionano Genomics reports Q4 revenue $10.7M, consensus $10.58M
Mar 05
7:05am ET
Options Volatility and Implied Earnings Moves Today, March 05, 2024
Feb 28
8:32am ET
BioNano Genomics Enhances Capital Structure and Flexibility
Feb 28
8:08am ET
Bionano Genomics announces amendment to debt financing arrangement
Feb 22
8:09am ET
Bionano Genomics says ACMG includes OGM in technical laboratory standards
Feb 02
7:31am ET
Analysts Are Bullish on Top Healthcare Stocks: BioNano Genomics (BNGO), Legend Biotech (LEGN)
Jan 30
8:14am ET
Bionano Genomics announces conclusion of 2024 Symposium
Jan 25
1:35pm ET
Maxim Group Remains a Hold on BioNano Genomics (BNGO)
Jan 25
8:14am ET
Bionano Genomics announces publication of study on OGM
Jan 24
8:03am ET
Bionano Genomics announces publication of second interim report of trial on OGM
Jan 23
8:07am ET
Bionano Genomics announces full commercial release of Stratys system
Jan 19
8:03am ET
Bionano Genomics announces final speaker lineup for 2024 Symposium
Jan 19
7:57am ET
Bionano Genomics price target lowered to $14 from $24 at Ladenburg
Jan 11
4:16pm ET
Bionano announces study results in support of establishing OGM as SOC
Jan 10
8:11am ET
Bionano Genomics announces 2024 Symposium
Jan 08
8:26am ET
Bionano Genomics sees FY23 revenue $35.8M-$36.1M, consensus $35.94M
Jan 08
8:25am ET
Bionano Genomics sees Q4 revenue $10.4M-$10.7M, consensus $10.54M
Jan 07
5:28am ET
BioNano Genomics (BNGO) Gets a Buy from BTIG
Jan 03
8:07am ET
Bionano Genomics announces OGM added to ISCN
Jan 03
8:06am ET
Bionano Genomics announces publication of framework paper for OGM-Dx HemeOne
Jan 02
9:10am ET
BTIG Keeps Their Buy Rating on BioNano Genomics (BNGO)
Dec 31
5:07am ET
BTIG Reaffirms Their Buy Rating on BioNano Genomics (BNGO)
Dec 28
8:06am ET
Bionano Genomics upgrades optical genome mapping pipeline
Dec 26
8:06am ET
Bionano Genomics announces publication comparing OGM to CMA and KT
No recent press releases are available for BNGO
BNGO Financials
Key terms
Ad Feedback
BNGO Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
BNGO Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range